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Patterns and predictors of smoking by race and medical diagnosis during
hospital admission: A latent class analysis
Abstract
Hospital-based tobacco treatment programs provide tobacco cessation for a diverse array of admitted
patients. Person-centered approaches to classifying subgroups of individuals within large datasets are
useful for evaluating the characteristics of the sample. This study categorized patients who received
tobacco treatment while hospitalized and determined whether demographics and smoking-related health
conditions were associated with group membership. Chart review data was obtained from 4854 patients
admitted to a large hospital in South Carolina, USA, from July 2014 through December 2019 who
completed a tobacco treatment visit. Smoking characteristics obtained from the visit interview were
dichotomized, and then latent class analysis (LCA) was conducted to categorize patients based on
smoking history and interest in stopping smoking. Finally, logistic regressions were used to evaluate
demographics and smoking-related health conditions as predictors of class membership. LCA generated
5 classes of patients, differentiated by heaviness of smoking and motivation to quit. Patients who were
black/African American were more likely to be lighter smokers compared to white patients. Hospitalized
patients with a history of hypertension, diabetes, and congestive heart failure were more likely to be
motivated to quit and also were more likely to be lighter smokers at the time of hospitalization.
Hospitalized patients who smoke and receive tobacco treatment are heterogeneous in terms of their
smoking histories and motivation to quit. Understanding latent categories of patients provides insight for
tailoring interventions and potentially improving tobacco treatment outcomes.
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Patterns and Predictors of Smoking by Race and Medical Diagnosis During Hospital
Admission: A Latent Class Analysis
Amanda M. Palmer, PhD*
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Georges J. Nahhas, PhD
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Brandon Sanford., PhD
K. Michael Cummings, PhD
& Alana M. Rojewski, PhD
Abstract
Hospital-based tobacco treatment programs provide tobacco cessation for a diverse array of
admitted patients. Person-centered approaches to classifying subgroups of individuals within large
datasets are useful for evaluating the characteristics of the sample. This study categorized patients
who received tobacco treatment while hospitalized and determined whether demographics and
smoking-related health conditions were associated with group membership. Chart review data was
obtained from 4854 patients admitted to a large hospital in South Carolina, USA, from July 2014
through December 2019 who completed a tobacco treatment visit. Smoking characteristics
obtained from the visit interview were dichotomized, and then latent class analysis (LCA) was
conducted to categorize patients based on smoking history and interest in stopping smoking.
Finally, logistic regressions were used to evaluate demographics and smoking-related health
conditions as predictors of class membership. LCA generated 5 classes of patients, differentiated
by heaviness of smoking and motivation to quit. Patients who were black/African American were
more likely to be lighter smokers compared to white patients. Hospitalized patients with a history
of hypertension, diabetes, and congestive heart failure were more likely to be motivated to quit
and also were more likely to be lighter smokers at the time of hospitalization. Hospitalized patients
who smoke and receive tobacco treatment are heterogeneous in terms of their smoking histories
and motivation to quit. Understanding latent categories of patients provides insight for tailoring
interventions and potentially improving tobacco treatment outcomes.
*Corresponding author can be reached at: palmeram@musc.edu
Introduction
Tobacco use is the leading cause of over 8
million preventable diseases and deaths
worldwide and is a contributing factor to
several leading causes of mortality, such as
heart disease and cancer (Barua et al., 2018;
Stanton et al., 2016). While 68% of people
who smoke express interest in cessation
(Babb et al., 2017), results have shown low
rates of long-term abstinence from unassisted
quit attempts (Hughes et al., 2013).
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Hospitals have an opportunity to provide
effective tobacco cessation support for
admitted patients given the potential for
increased motivation to quit and the smokefree policies many hospitals have in place.
“Opt-out” models, in which treatment is
provided as standard procedure, may be
especially suited for increasing motivation
and access to cessation treatment for a variety
of patients who may otherwise not have such
resources (Nahhas et al., 2017; Richter &
Ellerbeck, 2015). Studies have shown
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tobacco
treatment
programs
(TTPs)
incorporated into hospital and medical
systems are an effective way to increase
smoking cessation (Cartmell, Dooley, et al.,
2018; Miller et al., 1997; Nahhas et al., 2017;
Palmer et al., 2021; Rigotti et al., 2012;
Stevens et al., 1993), leading to a reduction in
morbidity and mortality rates for smoking
comorbidities (Mohiuddin et al., 2007; Smith
& Burgess, 2009; Van Spall et al., 2007).
However, cessation rates remain lower than
desired, and long-term abstinence is difficult
to achieve. Therefore, understanding
individual
differences
in
patient
presentations is critical to enhancing the
efficacy of these interventions.
Hospital admissions require the provider
to use time-efficient strategies to treat their
patients. Given the acute nature of the
hospital visit, time is limited for health
prevention services, and thus, is a barrier to
delivering individualized tobacco cessation
services (Rojewski et al., 2019; Stack &
Zillich, 2007). For this reason, strategies that
can facilitate service delivery while
maintaining personalized care are needed.
One such method for achieving efficiency is
to split patients into categories or groups
based on clinically relevant characteristics.
However, generation of patient groupings
can be subjective, which can lead to bias in
classification. A potentially less biased,
person-centered
approach,
involves
stratifying patients into groups using latent
class analysis (LCA). LCA is a statistical
modeling procedure that detects patterns
among observed variables and assigns a class
value based upon the likelihood each
subgroup encompasses their characteristics
(Ylioja et al., 2017). In a medical setting,
utilization of an LCA algorithm allows for
quick decision making by identifying
subgroups of patients based on key patient
characteristics (Lanza & Rhoades, 2013).
Latent subgroups can also be analyzed in
relation to one another to evaluate differences
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in representation of other related aspects,
such as patient demographics or health
conditions. This allows for future
intervention development strategies to tailor
treatments to latent subgroups to address
their unique needs. LCA has been used to
evaluate homogeneity in patterns of tobacco
use (e.g., Sutfin et al., 2009) and associated
correlates, such as dependence (e.g.,
Kypriotakis et al., 2018) and race and
ethnicity (e.g., Choi et al., 2018).
The present study used LCA to identify
latent patterns of smoking history and
motivation to quit among a large sample of
tobacco users who received a tobacco
treatment bedside consult while hospitalized.
Patient demographics and health conditions
were examined in relationship to group
membership to further distinguish identified
subgroups.
Methods
Participants
The Tobacco Treatment Program (TTP) at
the Medical University of South Carolina
(MUSC) is a dedicated service that treats
both inpatient and outpatient populations at
four different hospitals within the system
(Nahhas, Wilson, et al., 2017). Staff include
psychologists, pharmacists, and counselors,
who consist of pre-doctoral psychology
interns and a certified Tobacco Treatment
Specialist. Inpatient service is opt-out,
meaning that all patients are approached for
treatment and patients must actively decline
services (Nahhas, Cummings, et al., 2017). In
this program, counselors are alerted daily of
all patients admitted to the hospital that report
tobacco use. Counselors then visit patients in
their rooms to complete an interview, provide
brief counseling, and send medication orders
to attending physicians if requested and
accepted by the patient. Patients are then
enrolled in an automated, interactive voice
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recognition (IVR) protocol, wherein patients
are offered a referral to outpatient counseling
or the South Carolina Quitline. This program
has demonstrated clinical efficacy in
improving treatment outcomes, reducing
readmissions, and cutting costs (Cartmell,
Dismuke, et al., 2018; Cartmell, Dooley, et
al., 2018; Palmer et al., 2021).
Chart data were retrieved from patients
who were admitted to the hospital between
July 2014 and December 2019. Patients who
reported cigarette smoking, agreed to the
bedside
intervention,
and
accepted
enrollment into the IVR system were
included in the present analysis. Of those
identified, patient MRNs (medical record
numbers) were used to obtain data on history
of health conditions that are associated with
cigarette smoking. This study was exempt
from participant consent and approved by the
MUSC Institutional Review Board. Due to
the sensitive nature, the data are not shared
publicly.
Measures
Medical chart data. Patients’ age, race,
and biological sex were obtained from the
medical record. Data on history of health
conditions were pulled from each patient’s
chart on the day of admission (i.e., “Problem
List” via Epic electronic medical record
system) for the following: hypertension,
chronic obstructive pulmonary disease
(COPD), diabetes, heart failure, stroke, and
cancer. These conditions were chosen based
on those most prevalent among people who
smoke (Rojewski et al., 2016).
Smoking characteristics. TTP clinicians
asked patients to report on how long they had
been smoking (years), how often they
smoked over the past month (daily or nondaily), how many cigarettes were smoked per
day, how soon they smoked after waking, and
if they lived with another person who
smokes. These items were selected for use in
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the model based on previous literature that
suggests higher dependence may be related to
treatment
receptivity
and
outcomes
(Mussulman et al., 2019). Given the changing
landscape of tobacco product use in the
general population (Zhu et al., 2017) and
among hospitalized patients (Rigotti et al.,
2015), self-reported alternative tobacco
product use (cigars, oral tobacco, or ecigarettes) was collected for use in the model.
Patients were also asked how many times, if
any, they tried to quit smoking during the past
year. Importance to quit was measured by
asking “How important is quitting smoking
to you on a scale of 1-5, with 5 being the most
important?” Confidence in quitting was
measured by asking “How confident are you
that you will be able to remain smoke free on
a scale of 1-5, with 5 being the most
confident?” Motivational factors were
included in the model as hospitalization may
represent a “teachable moment” promoting
health behavior change, such as smoking
cessation (Dohnke et al., 2012). Finally,
patients were asked if they had requested and
received a quit smoking medication (such as
NRT, or nicotine replacement therapy)
during hospitalization. This variable is
especially salient to the patient’s physical
dependence, motivation, and receptivity to
treatment given the opt-out nature of the
program (Rigotti et al., 1999).
Statistical Methods
All analyses were conducted on Mplus
v8.1 and SAS 9.4. To begin, a median split
was used to dichotomize years smoking,
cigarettes per day, number of past-year quit
attempts, importance of quitting, and
confidence in quitting. Patients were
categorized based on responses to smoking
characteristics questions using LCA. This
analysis assumes that covariation among
variables measured is attributed to a single
latent factor (Lanza et al., 2003; Lanza &

3

Health Behavior Research, Vol. 5, No. 2 [2022], Art. 6

Rhoades, 2013). Preliminary models were
run to produce two latent classes, and further
iterations increased the number of classes.
Next, model fit and class differentiation was
interpreted (Nylund-Gibson & Choi, 2018).
Fit statistics (Akaike information criterion
[AIC], Bayesian information criterion [BIC],
sample-size adjusted BIC [SSA-BIC]) were
used to assess model fit and error, with lower
values indicating better fit. Entropy was used
to assess the degrees to which the classes
were inherently distinct from one another,
with increasing values implicating better
class distinction. Bootstrapped likelihood
ratio tests (BLRTs) compared the fit statistics
of each model iteration with the prior (k-1)
class iteration, with a significant difference
between models indicating a better fit.
Finally, models were subjectively interpreted
for content of classes. Once parsimony in
class interpretation decreased and BLRTs
failed to show better fit (p > .05), the LCA
iterations were terminated and the final
model was selected.
Unadjusted logistic regressions were used
to
evaluate
patient
demographic
characteristics (sex and race), and smokingrelated health condition diagnosis as
predictors of class membership.
Results
Patient Characteristics
Chart review identified 4,854 patients who
reported current cigarette smoking upon
admission and completed an interview with
the
TTP
while
inpatient.
Patient
demographics can be seen in Table 1. On
average, participants were middle aged,
male, and identifying as either white or
black/African American. A majority of
patients reported daily smoking, averaging
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about 15 cigarettes per day and a smoking
history of approximately 27 years. Only 288
(5.9%) of patients reported current use of an
alternative tobacco product, such as cigars, ecigarettes, or oral tobacco.
Median splits dichotomized smoking
characteristics into the following variables
(affirmative or negative): high cigarettes per
day (≥ 15 cigarettes per day), high smoking
history (≥ 28 years smoking history), high
dependence (smoke within first 5 minutes of
waking), made past year quit attempt (≥ 1
quit attempt in the past year), high
importance of quitting (≥ 4 on 1-5 scale), and
high confidence in the ability to quit (≥ 4 on
1-5 scale). Daily smoking status, living with
another person who smokes, use of any other
tobacco products, and receipt of NRT
remained dichotomized as affirmative or
negative for the analysis. Medical diagnoses
from the problem list were obtained from
4,516 (93.03%) patients. Those with missing
data were coded as not having the diagnosis
of interest.
Class Models
Six iterative models were run, and fit
statistics can be seen in Supplemental Table
1. Model fit indices showed the data fit best
into 5 latent classes, shown in Figure 1. Fit
statistics for this model were as follows: AIC
= 47451.46; BIC = 47801.79; SSA-BIC:
47630.198; entropy = 0.70. BLRTs showed
that the 5-class model was a superior fit to the
4-class model (p < .001), but the 6-class
model was not superior to the 5-class model
(p = .0197).
In general, the probability of using an
alternative product was very low across
classes, and the probabilities of long-term
smoking and of living with another person
who smokes were moderate.
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Table 1. Patient Demographics and Smoking Characteristics
Characteristic (N = 4854)

Age
Sex
Male
Female
Race/Ethnicity
White
Black/African American
Hispanic
American Indian/Alaska Native
Asian
Mixed/ Other
Daily smoking
Cigarettes per day
Years smoking
Time to first cigarette
< 5 minutes
6-30 minutes
31-60 minutes
> 61 minutes
Unmotivated Heavy Smoking (UHS); n =
1396, 28.8%

The first class identified all reported daily
smoking and showed high probabilities of
reporting high dependence and heavy
cigarette smoking. In addition, this group had
low probabilities of attempting to quit in the
past year, rating quitting as important, and
reporting high confidence in their ability to
quit. This group had a relatively high
probability of receiving medications while
hospitalized.
Motivated Heavy Smoking (MHS); n =
1381; 28.5%
The second class identified had all
reported high dependence and also showed

Published by New Prairie Press, 2022

M or N
45.35

SD or %
25.17

2647
2206

54.5%
45.5%

2628
1480
62
22
15
14
3906
15.9
27.9

62.3%
35.1%
1.5%
< 1%
< 1%
< 1%
80.5%
11.26
15.59

2266
531
247
434

46.7%
10.9%
5.1%
8.9%

high probabilities of daily smoking and
heavy cigarette smoking. This group also
showed high probabilities of having a past
year quit attempt, receiving medications in
the hospital, and reporting high importance of
and confidence in quitting.
Unmotivated Light Smoking (ULS); n = 688,
14.2%
In the Unmotivated Light Smoking class,
there was a lower likelihood of respondents
reporting daily smoking, high dependence,
and heavy smoking as compared to the prior
two classes. Similar to UHS, these patients
reported lower likelihoods of past year quit
attempts, endorsing quitting as high in
importance, and reporting high confidence in
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1
0.9

Probability of Affirmative Response

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

Smoking >28 Uses another
Daily smoking Smoking >15
Smokes
Years
tobacco
CPD
within 5 mins
product
of waking
Class
UHS 1

Class
MHS2

Lives with
another
smoker

Class
ULS 3

Importance to Confidence to Past year quit Received
quit > 4
quit > 4
attempt
medication in
hospital

Class
MLS4

Class
5
MVLS

Figure 1. Probabilities of responding affirmatively to dichotomized variables in the LCA. Note. UHS = Unmotivated Heavy Smoking;
MHS = Motivated Heavy Smoking; ULS = Unmotivated Light Smoking; MLS = Motivated Light Smoking; MVLS = Motivated Very
Light Smoking. CPD = cigarettes per day.
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Supplemental Table 1. Model Fit Statistics
2 class

3 class

4 class

5 class

6 class

AIC: 48307.899

AIC: 47709.651

AIC: 47517.389

AIC: 47451.463

AIC: 47408.786

BIC: 48444.137

BIC: 47917.253

BIC: 47796.354

BIC: 47801.791

BIC: 47830.477

SSA-BIC:
48377.407

SSA-BIC:
47815.568

SSA-BIC:
47659.716

SSA-BIC:
47630.198

SSA-BIC:
47623.930

Entropy: 0.890

Entropy: 0.756

Entropy: 0.687

Entropy: 0.701

Entropy: 0.698

BLRT 3- vs 2class: p < .00001

BLRT 4- vs 3class: p < .00001

BLRT 5- vs 4class: p < .0001

BLRT 6- vs 5class: p < .0197

Note. AIC = Akaike Information Criterion; BIC = Bayesian Information Criterion; SSA-BIC =
Sample-size Adjusted BIC; BLRT = Bootstrapped likelihood ratio tests.
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quitting. However, this class had lower probabilities than the first two of receiving
medications while hospitalized.
Motivated Light Smoking (MLS); n = 895,
18.4%
The fourth identified class were nearly all
smoking daily, although none reported high
dependence. This group had a low probability
of reporting heavy smoking, but high
probabilities of receiving a medication while
hospitalized, reporting a past year quit
attempt, high importance of quitting, and
high confidence in quitting.
Motivated Very Light Smoking (MVLS); n =
494, 10.2%
The final class identified had the lowest
probability of daily smoking relative to the
other classes. This class also had relatively
low probabilities of reporting high
dependence, high cigarette smoking, or
receiving a medication while admitted.
Despite this, probabilities of endorsing high
importance of quitting and high confidence in
quitting were high.
Predictors of Class Membership
Based on the distribution of racial identity
within our patient sample, we collapsed race
into three categories to use as predictors of
class membership: white, black/African
American, and other. Table 2 shows numeric
counts of each characteristic per class and
Table 3 presents unadjusted odds ratios
(ORs) with 95% confidence intervals (CIs)
for each class comparison.
Overall, black/African American patients
were more likely to fall into ULS (OR = 1.88
[1.55 -2.29]), MLS (OR = 1.65 [1.37 - 1.97]),
and MVLS (OR = 1.92 [1.54 - 2.38)
compared to UHS. These patients were also
less likely to fall into MHS compared to ULS
(OR = 0.49 [0.40 - 0.60]), MLS (OR = 0.56
[0.47 - 0.68]), and MVLS (OR = 0.48 [0.39
0.60]). White patients were more likely to fall
https://newprairiepress.org/hbr/vol5/iss2/6
DOI: 10.4148/2572-1836.1129

into MHS compared to ULS (OR = 1.83 [1.52
-2.21]), MLS (OR = 1.62 [1.37 - 1.92]) and
MVLS (OR = 1.76 [1.43 - 2.17]).
Additionally, white patients were less likely
to be in ULS (OR = 0.62 [0.51 - 0.74], MLS
(OR = 0.70 [0.59 - 0.82]), and MVLS (OR =
0.64 [0.52 - 0.79]), relative to UHS. Sex only
had an effect on MHS relative to MVLS, such
that males were less likely to fall into MHS
(OR = 0.80 [0.65 - 0.98]).
Individuals who fell into MLS were more
likely to have hypertension (OR = 1.32 [1.10
- 1.59]), diabetes (OR = 1.50 [1.18 - 1.91]),
and congestive heart failure (OR = 1.66 [1.21
- 2.27]), but less likely to have cancer (OR =
0.71 [0.52 - 0.97]), compared to UHS. Those
who had congestive heart failure were more
likely to fall into MHS (OR = 1.46 [1.00 2.14]) compared to ULS, but less likely to fall
into ULS (OR = 0.55 [0.37 - 0.81]) compared
to MLS. Those who had a stroke were more
likely to fall into ULS (OR = 1.97 [1.07 3.61]) and MLS (OR = 2.01 [1.12 - 3.60]),
compared to MVLS. Finally, those who had
diabetes were less likely to fall into MHS
(OR = 0.62 [0.48 - 0.79]) compared to MLS,
and those who had hypertension were more
likely to fall into MLS (OR = 1.34 [1.05 1.71]) compared to MVLS.
Discussion
Inpatient TTPs have the ability to reach a
broad range of patients to promote tobacco
cessation. To examine these extensive,
generalized programs, analytic strategies that
account for multiple variables and identify
natural patterns are required. The present
analysis sought to characterize a large group
of patients treated by the MUSC TTP based
on responses during the bedside interview.
Using LCA, 5 unique classes of patients
emerged. In general, classes were
differentiated based on smoking frequency
and motivation to stop smoking, and were
named as follows: Motivated Heavy
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Table 2. Patient Characteristics Within Class
UHS

MHS

ULS

MLS

MVLS

Unmotivated Heavy
Smoking

Motivated Heavy
Smoking

Unmotivated Light
Smoking

Motivated Light
Smoking

Motivated Very
Light Smoking

n = 1396

n = 1381

n = 688

n = 895

n = 494

Male (n = 2206)

640 (45.85%)

600 (43.45%)

310 (45.06%)

414 (46.31%)

242 (48.99%)

Black Race (n = 1480)

356 (25.50%)

335 (24.26%)

270 (39.24%)

323 (36.09%)

196 (39.68%)

White Race (n = 2628)

805 (57.66%)

840 (60.83%)

315 (45.78%)

437 (48.83%)

231 (46.76%)

Other Race (n = 746)

235 (16.83%)

206 (14.92%)

103 (14.97%)

135 (15.08%)

67 (13.56%)

Hypertension (n = 1353)

360 (25.79%)

383 (27.73%)

202 (29.36%)

282 (31.51%)

126 (25.51%)

93 (6.66%)

76 (5.50%)

37 (5.38%)

49 (5.47%)

17 (3.44%)

160 (11.46%)

150 (10.86%)

90 (13.08%)

146 (16.31%)

70 (14.17%)

84 (6.02%)

109 (7.89%)

38 (5.52%)

86 (9.61%)

38 (7.69%)

66 (4.73%)

69 (5.00%)

40 (5.81%)

53 (5.92%)

15 (3.04%)

62 (6.93%)

39 (7.89%)

Full Sample N = 4854
Characteristic (n, %)

COPD (n = 272)
Diabetes (n = 616)
Congestive Heart Failure
(n = 355)
Stroke (n = 243)

Cancer (n = 418)
132 (9.46%)
127 (9.20%)
58 (8.43%)
Note. Percentages represent within class counts; counts for predictor variables are included for reference.
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Table 3. Patient Characteristics as Independent Predictors of Class Membership
Characteristic
Male
Black Race
White Race
Other Race
Hypertension
COPD
Diabetes
Congestive Heart
Failure
Stroke
Cancer

Class Comparison
OR (95% CI)

MHS vs
UHS
0.90
(0.78 - 1.05)
0.93
(0.78 - 1.11)
1.14
(0.98 - 1.32)
0.86
(0.70 - 1.06)

ULS vs
UHS
0.96
(0.80 - 1.16)
1.88
(1.55 -2.29)
0.62
(0.51 - 0.74)
0.87
(0.67 - 1.11)

MLS vs
UHS
1.01
(0.86 - 1.20)
1.65
(1.37 - 1.97)
0.70
(0.59 - 0.82)
0.87
(0.69 - 1.10)

MVLS vs
UHS
1.13
(0.92 - 1.39)
1.92
(1.54 - 2.38)
0.64
(0.52 - 0.79)
0.77
(0.57 - 1.03)

MHS vs
ULS
0.93
(0.77 - 1.12)
0.49
(0.40 - 0.60)
1.83
(1.52 -2.21)
0.99
(0.77 -1.28)

MHS vs
MLS
0.89
(0.75 - 1.05)
0.56
(0.47 - 0.68)
1.62 (1.37 1.92)
0.98 (0.78 1.24)

MHS vs
MVLS
0.80
(0.65 - 0.98)
0.48
(0.39 0.60)
1.76
(1.43 - 2.17)
1.11
(0.83 - 1.50)

ULS vs
MLS
0.95
(0.77 - 1.16)
1.14
(0.93 - 1.40)
0.88
(0.72 - 1.08)
0.99
(0.75 - 1.30)

ULS vs
MVLS
0.85
(0.67 - 1.07)
0.98
(0.77 - 1.24)
0.96
(0.76 - 1.21)
1.12
(0.80 - 1.56)

MLS vs
MVLS
0.89
(0.72 - 1.11)
0.85
(0.68 - 1.07)
1.08
(0.87 - 1.35)
1.13
(0.82 - 1.55)

1.10
(0.93 - 1.30)
0.81
(0.59 - 1.11)
0.94
(0.74 - 1.19)
1.33
(0.99 - 1.79)
1.06
(0.75 - 1.49)
0.97
(0.75 - 1.25)

1.19
(0.97 - 1.46)
0.79
(0.53 - 1.17)
1.16
(0.88 - 1.53)
0.91
(0.61 - 1.35)
1.24
(0.83 - 1.86)
0.88
(0.63 - 1.21)

1.32
(1.10 - 1.59)
0.81
(0.56 - 1.15)
1.50
(1.18 - 1.91)
1.66
(1.21 - 2.27)
1.26
(0.87 - 1.83)
0.71
(0.52 - 0.97)

0.98
(0.77 - 1.24)
0.49
(0.29 - 0.84)
1.27
(0.94 - 1.72)
1.30
(0.87 - 1.93)
0.63
(0.35 - 1.11)
0.82
(0.56 - 1.19)

0.92
(0.75 - 1.13)
1.02
(0.68 - 1.53)
0.81
(0.61 - 1.07)
1.46
(1.01 - 2.14)
0.85
(0.57 - 1.27)
1.10
(0.79 - 1.52)

0.83
(0.69 - 1.00)
1.00
(0.69 - 1.45)
0.62
(0.48 - 0.79)
0.80
(0.60 - 1.08)
0.83
(0.57 - 1.20)
1.36
(0.99 - 1.86)

1.12
(0.88 - 1.41)
1.63
(0.95 - 2.79)
0.73
(0.54 - 1.00)
1.02
(0.70 - 1.51)
1.67
(0.95 - 2.96)
1.18
(0.81 - 1.71)

0.90
(0.72 - 1.12)
0.98
(0.63 - 1.52)
0.77
(0.58 - 1.02)
0.55
(0.37 - 0.81)
0.98
(0.64 - 1.49)
1.23
(0.85 - 1.79)

1.21
(0.93 - 1.57)
1.59
(0.88 - 2.86)
0.91
(0.65 - 1.27)
0.70
(0.44 - 1.11)
1.97
(1.07 - 3.61)
1.07
(0.70 - 1.64)

1.34
(1.05 - 1.71)
1.62
(0.92 - 2.85)
1.18
(0.86 - 1.60)
1.27
(0.85 - 1.90)
2.01
(1.12 - 3.60)
0.86
(0.57 - 1.31)

Note. Unadjusted models. OR = odds ratio; CI = Confidence interval. Bolded results indicate p < .001.
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Smoking, Unmotivated Heavy Smoking,
Motivated Light Smoking, Unmotivated
Light Smoking, Motivated Very Light
Smoking.
Of note, patients in all classes reported
low rates of alternative tobacco use, which
likely contributed to some overlap within the
classes. This is evidenced by the entropy of
.07, which is slightly lower than ideal. Had
this variable been removed from the present
model and the LCA re-run, it is likely that
more distinct classes would have emerged.
Future iterations of LCA within patient
samples from this hospital system may
improve in model fit with this adjustment;
however, because of the evolving availability
and popularity of alternative tobacco
products, such as e-cigarettes (Rigotti et al.,
2015; Zhu et al., 2017), polytobacco use
among hospital patients should continue to be
monitored and included in evaluations of
patient characteristics. Indeed, prior LCA
studies have demonstrated heterogeneity of
tobacco product use and the association with
dependence (Kypriotakis et al., 2018).
Demographic variables (gender and race)
were tested as predictors of class
membership. Consistent with population
surveys, our sample of hospitalized smokers
found that white patients were more likely to
be classified in the heavy smoking subgroups
groups, while black/African American
patients were more likely to be classified in
the lighter smoking groups (Trinidad et al.,
2011). Despite lower average reported
smoking frequencies, the black/African
American patients in our sample had a higher
prevalence of smoking-related illnesses,
which is consistent with population studies
(Park et al., 2011). Marginalized populations,
such as black/African Americans, tend to
have more barriers for accessing and
receiving treatment resources for health
conditions as well as smoking cessation.
Additionally, a growing body of literature
supports the notion that tobacco companies
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aggressively targeted these communities with
menthol cigarettes (Alexander et al., 2016),
leading to the tobacco-related health
disparities present in population surveys and
the current study.
In the present study, patients were more
likely to be classified as Motivated Light
Smoking (MLS) than Unmotivated Heavy
Smoking (UHS) if they had hypertension,
diabetes, and congestive heart failure
indicated in the “problem list” on their
medical chart. The lower frequency of
smoking found among patients who reported
a history of chronic illnesses is opposite to
what might be expected given the wellestablished dose-dependent association
between smoking and disease. However,
there are several possible explanations that
can explain this finding. First, the
demographic makeup of these classes differ
in ways that are consistent with both smoking
frequency and chronic disease prevalence.
Indeed, black/African Americans have higher
rates of hypertension, diabetes, and
congestive heart failure overall, and among
those who smoke report smoking at lower
rates compared to their white counterparts
(Ho & Elo, 2013).
Another explanation might be that patients
with a known history of chronic illnesses who
are hospitalized will report smoking less,
because they are more motivated to stop
smoking, perhaps in response to a diagnosis
of a smoking-related disease. This finding is
partially supported by the observation that
those with congestive heart failure were more
likely to be classified into classes with higher
levels of motivation to quit (MHS, MLS)
than those with lower evidence of motivation
(UHS, ULS). In addition, those with COPD,
stroke, and diabetes were less likely to be
categorized as Motivated Very Light
Smoking (MVLS) compared to some other
classes.
In general, our findings show that
hospitalized patients who smoke and receive

11

Health Behavior Research, Vol. 5, No. 2 [2022], Art. 6

tobacco treatment are heterogeneous in terms
of their smoking histories and motivation to
quit. Understanding latent categories of
patients provides insight for tailoring
interventions and potentially improving
tobacco treatment outcomes, consistent with
suggestions from previously published LCAs
on tobacco use that demonstrated significant
heterogeneity of characteristics between
classes of individuals who smoke (e.g., Sutfin
et al, 2009). For instance, treatments may be
tailored for the stage of change the
hospitalized patients are in, or the degree of
salience the teachable moment has on
thoughts of changing smoking behavior.
Differences
in
tobacco
dependence
characteristics within classes is consistent
with previous research (Kypriotakis et al.,
2018) and supports the use of personalized
pharmacotherapy recommendations during
admission and upon discharge. Our findings
suggest subgroups based on smoking
frequency and motivation to quit are
moderated by race and history of smoking
related diseases. Understanding these characteristics may inform recommendations to best
mitigate withdrawal symptoms while
remining mindful of other health
symptomology that may be occurring. Our
results also support maintaining inpatient
treatment programs at hospitals, as they are
able to have a broad impact on diverse patient
populations. Program elements need not be
specific or overly intensive, but rather can
provide general support for patients, which
allows for an increased number of patients
who can receive treatment (Palmer et al.,
2021). Programs should continue to conduct
descriptive and quality improvement
research to maintain funding resources and
improve clinical services.
Limitations
There are several limitations of the present
analysis that should be considered within the
context of the results. First, the data are cross-
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sectional and therefore longitudinal transitions in smoking patterns, motivation, and
the diagnosis of health conditions are unable
to be determined. Second, there was no nonsmoking control group (i.e., either never
smoker or former smoker) used for reference,
which limits interpretations of health risk to
relative comparisons between those who
currently smoke. However, the present study
provides a foundation for which future
research could develop longitudinal studies
to assess smoking, chronic health conditions,
and the role of interventions embedded
within medical settings. Third, there are
limitations associated with the use of LCA as
used in this study. Dichotomizing continuous
variables based on median split can result in
a loss of information. Future research might
consider latent profile analyses or latent
transition analyses to assess more complex
trends in patient data. An additional
consideration is the lack of validation of the
final model generated in the present study.
That is, the classes that emerged from the
LCA were not statistically confirmed on an
additional sample, which reduces the
generalizability of our findings. Future
research can confirm these classes within the
hospital system used in the present study as
well as with samples from other hospitals.
Missing data from the patient assessment
interviews also introduce bias into the
analyses. Finally, the influence of patient
class on downstream measures of smoking
cessation could not be assessed due to low
response to our post-discharge IVR followup to assess smoking status.
Implications for Health Behavior Theory
Advanced, person-centered methodological approaches can be used to accurately
an efficiently characterize and evaluate large
samples. This study illustrates the application
of such approaches to inform program
evaluation. LCA was used to differentiate
categories of patients receiving tobacco
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treatment from an inpatient hospital service.
Among patients receiving a brief, inpatient
tobacco treatment bedside consult, LCA
identified 5 classes differing in smoking
frequency and motivation to quit. Consistent
with established estimates of tobacco-related
health disparities, race/ethnicity and history
of smoking-related health conditions were
predictive of class membership in the present
study. The varying compositions of patient
classes suggest that multiple influences may
be contributing to the tobacco use patterns in
each class in addition to the associated health
and sociodemographic conditions. With a
better understanding of these associations,
tobacco treatment interventions can become
tailored to address specific needs.
At an individual level, there is evidence
that brief, nonspecific tobacco treatment
interventions embedded in an inpatient
hospital admission are effective at initiating
quit attempts and promoting abstinence,
although there remains substantial room for
improvement. Using a person-centered
analytical approach to categorize patients
allows for a more accurate assessment of
patient characteristics and groupings. Future
research can evaluate the efficacy of tobacco
treatment interventions between these
groups, and assess specific barriers to
quitting. This knowledge will allow
clinicians to tailor treatments to each groups’
specific needs, thus improving outcomes.
Broad interventions, such as the program
described, may also help to address racial
health disparities by providing access to
treatment and specific resources to
individuals who may otherwise have not had
assistance with quitting tobacco. At the
hospital or organizational level, LCA on
large patient samples undergoing tobacco
treatment can be used to obtain additional
resources from administration and other key
stakeholders. That is, LCA can be used to
describe the general characteristics of
patients engaging with the program at the
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hospital, and any differences in treatment
delivery and outcomes that might exist
between certain groups. Interventions may
then be tailored for stage of change, most
effective pharmacotherapy, and postdischarge resources to ensure patents receive
comprehensive services that meet their
specific needs. A strong program analysis
may justify allocating funds, training, staff,
grants, and other resources to improving the
tobacco treatment program as a whole and for
special populations (Palmer et al., 2021).
Importantly, evaluating cost-savings as a
result of changes in health outcomes
following treatment is critical for retaining
funding for tobacco treatment programs.
Finally, findings from LCAs of hospital
patients can be extended into the community,
in that the patient sample represents the
individuals in the surrounding area. Hospital
systems and community organizations may
collaborate to provide tailored smoking
cessation services to the public to encourage
post-discharge maintenance of tobacco
abstinence, as well as develop smoking
prevention programs for those who are risk of
starting.
Discussion Questions
1. Findings indicate that patients receiving
inpatient tobacco treatment can be
grouped into distinct classes based on
level of smoking and motivation to quit.
Moreover, these classes vary in
sociodemographic makeup and health
conditions present. How might inpatient
tobacco treatment interventions be
tailored to address the specific
characteristics of the patient classes
found in the present study?
2. In the present study, different
sociodemographic characteristics and
health conditions were related to class
membership. What should future
researchers do to further evaluate the
relationships between classes of patients
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who smoke, sociodemographics, and
tobacco-related health conditions?
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